TAVI in LOW RISK in the REAL WORLD

NCT07605780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2026-05-26

No results posted yet for this study

Summary

The primary objective is to assess all-cause mortality, the occurrence of stroke, or rehospitalization for cardiovascular causes in low-risk "all-comers" patients following percutaneous aortic valve replacement

Conditions

  • Aortic Valve Stenosis

Sponsors & Collaborators

  • Fondazione Poliambulanza Istituto Ospedaliero

    collaborator OTHER
  • Centro Cardiologico Monzino

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-13
Primary Completion
2025-08-24
Completion
2025-08-24

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07605780 on ClinicalTrials.gov